These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1440532)

  • 1. Reduction of the anticoagulant activity of glycosaminoglycans on the surface of the vascular endothelium by endotoxin and neutrophils: evaluation by an amidolytic assay.
    Heyderman RS; Klein NJ; Shennan GI; Levin M
    Thromb Res; 1992 Sep; 67(6):677-85. PubMed ID: 1440532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin and neutrophils.
    Klein NJ; Shennan GI; Heyderman RS; Levin M
    J Cell Sci; 1992 Aug; 102 ( Pt 4)():821-32. PubMed ID: 1429895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syndecan-4-dependent signaling in the inhibition of endotoxin-induced endothelial adherence of neutrophils by antithrombin.
    Kaneider NC; Förster E; Mosheimer B; Sturn DH; Wiedermann CJ
    Thromb Haemost; 2003 Dec; 90(6):1150-7. PubMed ID: 14652650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermatan sulfate is the predominant antithrombotic glycosaminoglycan in vessel walls: implications for a possible physiological function of heparin cofactor II.
    Tovar AM; de Mattos DA; Stelling MP; Sarcinelli-Luz BS; Nazareth RA; Mourão PA
    Biochim Biophys Acta; 2005 Apr; 1740(1):45-53. PubMed ID: 15878740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells.
    Nishinaga M; Ozawa T; Shimada K
    J Clin Invest; 1993 Sep; 92(3):1381-6. PubMed ID: 8376590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombin III modulates the effect of thrombin on the metabolism of glycosaminoglycans in cultured endothelial cells.
    Akai T; Kaji T; Hayakawa Y; Hayashi T; Sakuragawa N
    Thromb Res; 1991 Jun; 62(6):707-16. PubMed ID: 1926061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of tissue factor pathway inhibitor to cultured endothelial cells-influence of glycosaminoglycans.
    Iversen N; Sandset PM; Abildgaard U; Torjesen PA
    Thromb Res; 1996 Nov; 84(4):267-78. PubMed ID: 8948051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of cell surface glycosaminoglycans (GAGs) on the inactivation of factor VIIa--tissue factor activity by antithrombin III.
    Hamamoto T; Kisiel W
    Int J Hematol; 1998 Jul; 68(1):67-78. PubMed ID: 9713170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombin effects on endotoxin-induced microcirculatory disorders are mediated mainly by its interaction with microvascular endothelium.
    Hoffmann JN; Vollmar B; Römisch J; Inthorn D; Schildberg FW; Menger MD
    Crit Care Med; 2002 Jan; 30(1):218-25. PubMed ID: 11902265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glycosaminoglycans and inhibitors (antithrombin III and heparin cofactor II)].
    Sakuragawa N
    Nihon Rinsho; 1989 Apr; 47(4):759-65. PubMed ID: 2746884
    [No Abstract]   [Full Text] [Related]  

  • 11. Blueberry metabolites restore cell surface glycosaminoglycans and attenuate endothelial inflammation in diabetic human aortic endothelial cells.
    Cutler BR; Gholami S; Chua JS; Kuberan B; Anandh Babu PV
    Int J Cardiol; 2018 Jun; 261():155-158. PubMed ID: 29544868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular Histones Bind Vascular Glycosaminoglycans and Inhibit the Anti-Inflammatory Function of Antithrombin.
    Biswas I; Panicker SR; Cai XS; Giri H; Rezaie AR
    Cell Physiol Biochem; 2021 Oct; 55(5):605-617. PubMed ID: 34655467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-like glycosaminoglycans inhibit leukocyte adhesion to endotoxin-activated human vascular endothelial cells under nonstatic conditions.
    Kitamura N; Yamaguchi M; Shimabukuro K; Miyasaka M; Nakano H; Kumada K
    Eur Surg Res; 1996; 28(6):428-35. PubMed ID: 8954319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of thrombin with heparin cofactor II and antithrombin III on prostacyclin production by cultured endothelial cells.
    Kaji T; Itoh F; Hayakawa Y; Oguma Y; Sakuragawa N
    Thromb Res; 1989 Oct; 56(1):99-107. PubMed ID: 2512688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-like glycosaminoglycan is a receptor for antithrombin III-dependent but not for thrombin-dependent prostacyclin production in human endothelial cells.
    Horie S; Ishii H; Kazama M
    Thromb Res; 1990 Sep; 59(6):895-904. PubMed ID: 2175954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of abnormal antithrombin-III Toyama with cultured porcine aortic endothelial cells.
    Saito S; Takahashi K; Sakuragawa N
    Thromb Res; 1988 Apr; 50(1):19-25. PubMed ID: 3400080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial cell injury induced by plasmin in vitro.
    Okajima K; Abe H; Binder BR
    J Lab Clin Med; 1995 Oct; 126(4):377-84. PubMed ID: 7561447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of glycosaminoglycans and fibronectin on endotoxin-stimulated endothelium by adherent neutrophils: relationship to CD11b/CD18 and L-selectin expression.
    Klein NJ; Levin M; Strobel S; Finn A
    J Infect Dis; 1993 Apr; 167(4):890-8. PubMed ID: 7680700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III.
    Koyama T; Parkinson JF; Sié P; Bang NU; Müller-Berghaus G; Preissner KT
    Eur J Biochem; 1991 Jun; 198(3):563-70. PubMed ID: 1646716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and functional characterization of glycosaminoglycans released from degranulating rat peritoneal mast cells: Insights into the physiological role of endogenous heparin.
    Lever R; Smailbegovic A; Riffo-Vasquez Y; Gray E; Hogwood J; Francis SM; Richardson NV; Page CP; Mulloy B
    Pulm Pharmacol Ther; 2016 Dec; 41():96-102. PubMed ID: 27816772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.